NCT03076801

Brief Summary

This pilot randomized control trial will examine the role of choral singing on psychosocial stress and cardiovascular outcomes in patients with ischemic heart disease (IHD). The hypothesis is that choral singing will improve psychosocial stress in comparison to the control group and this may have an impact on rates of hospitalization, death, myocardial infarction and stroke in these patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 10, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

September 25, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2018

Completed
Last Updated

November 26, 2018

Status Verified

November 1, 2018

Enrollment Period

10 months

First QC Date

February 24, 2017

Last Update Submit

November 22, 2018

Conditions

Keywords

Choral SingingMusicQuality of LifePsychosocial StressCardiac Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Psychosocial Stress

    Change in a composite measure of stress from baseline to 3 months and 6 months is the Primary Outcome Measure. This composite measure of stress is comprised of of the Perceived Stress Scale (PSS), Hospital Anxiety and Depression Scale (HADS) and the Standard Form - 36 (SF - 36). Individual scores for the three scales will be determined for each participant at baseline, 3 and 6 months. These scores will be converted to the same scale and averaged with each component weighted equally to determine the composite stress score for each participant.

    Baseline, 3 months and 6 months

Secondary Outcomes (5)

  • Rate of hospitalization.

    12 months

  • Rates of death.

    12 months

  • Rates of myocardial infarction .

    12 months

  • Rates of stroke.

    12 months

  • Intervention adherence

    3 months

Other Outcomes (1)

  • Qualitative Feedback

    3 months

Study Arms (2)

Choral Singing Intervention

EXPERIMENTAL

In addition to usual medical care, participants in the intervention group will participate in choral singing.

Behavioral: Choral Singing

Control

NO INTERVENTION

The control group will receive usual medical care only. If control group participants join an external singing group during the study period they will not be excluded, but this data will be collected and considered.

Interventions

Choral SingingBEHAVIORAL

In addition to usual medical care, participants in the intervention group will participate in weekly 60-90 minute singing sessions led by professional musicians over a 12-week period. Sessions will begin with a 5-minute physical warm-up of gentle stretching and a 5-minute vocal warm-up. Music will be selected from a variety of genres and eras. Attendance will be taken weekly.

Choral Singing Intervention

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must have a history of myocardial infarction or acute coronary syndrome and have undergone cardiac rehabilitation. All levels of musical ability and past experience will be included.

You may not qualify if:

  • Participants unable to respond to English questionnaires will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart and Lung Wellness Centre

Sydney, Nova Scotia, B1S 0H5, Canada

Location

MeSH Terms

Conditions

Myocardial IschemiaCoronary DiseaseMyocardial Infarction

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Paul MacDonald, MD

    Nova Scotia Health Authority

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The investigator will be blind to participant allocation during chart review at 12 months.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Paul MacDonald

Study Record Dates

First Submitted

February 24, 2017

First Posted

March 10, 2017

Study Start

September 25, 2017

Primary Completion

July 26, 2018

Study Completion

October 5, 2018

Last Updated

November 26, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations